Clinuvel Pharmaceuticals Ltd
ASX:CUV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
AU |
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
DE |
|
G50 Corp Ltd
OTC:GFTYF
|
AU |
|
Hiro Brands Ltd
ASX:HRO
|
AU |
|
T
|
Thaivivat Insurance PCL
SET:TVI
|
TH |
|
G
|
Grupo Concesionario del Oeste SA
BCBA:OEST
|
AR |
|
L
|
Lithium Ionic Corp
XTSX:LTH
|
CA |
|
Brioschi Sviluppo Immobiliare SpA
MIL:BRI
|
IT |
|
O
|
Oversea Enterprise Bhd
KLSE:OVERSEA
|
MY |
|
M
|
mPlus Corp
KOSDAQ:259630
|
KR |
|
electroCore, Inc.
NASDAQ:ECOR
|
US |
|
Insight Molecular Diagnostics Inc
NASDAQ:IMDX
|
US |
|
Mayur Resources Ltd
ASX:MRL
|
AU |
|
S
|
Sabina PCL
SET:SABINA
|
TH |
|
V
|
VSTECS Holdings Ltd
HKEX:856
|
HK |
|
American Superconductor Corp
NASDAQ:AMSC
|
US |
Bankruptcy Probability
Clinuvel Pharmaceuticals Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Clinuvel Pharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
467.9m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Clinuvel Pharmaceuticals Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Clinuvel Pharmaceuticals Ltd has total debt of 17.3k AUD. This includes both short-term (0 AUD) and long-term (17.3k AUD) debt.
You can find a full breakdown on its Balance Sheet.
